F2 and thrombophilia: The heterozygous Factor V Leiden mutation (13.1%) was the most prevalent risk factor for thrombophilia, followed by the heterozygous Prothrombin G20210A mutation (4.8%) and the combined heterozygous Prothrombin G20210A and Factor V Leiden mutation (3.2%).